Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-25 @ 2:13 AM
NCT ID:
NCT00916760
Eligibility Criteria:
Inclusion Criteria:
* Informed consent, signed by the subject
* Positive clinical history of rhinitis/rhinoconjunctivitis allergy to Parietaria pollen
* Patient of both gender aged from 18 up to 55
* Diagnosed Sensitivity to Parietaria pollen base on:
Positive Nasal provocation test Positive prick test to P. Judaica Specific IgE to P.Judaica \>0,7KU/L
\- Patients who are able to comply with the dose regime
Exclusion Criteria:
* Relevant sensitivity to another perenne allergen
* Patient with asthma
* Use of immunotherapy during the last four years
* Treatment with B. Blocking agents
* Patient suffering from some pathology in which adrenaline was contraindicated
* Subject suffers from a serious medical condition, which would interference the treatment and follow up of the subject in the study
* Subject suffers from autoimmune disease(thyroiditis, lupus, etc.)
* Conditions in which the patient can not offer full co-operation nad significant psychiatric disturbance.
* Intolerance to aspirin
* Pregnant women or with pregnancy risk and brest-feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT00916760
Study Brief:
Protocol Section:
NCT00916760